# FDA 483 - California Fertility Centers, A Medical Corporation - January 24, 2020

Source: https://www.keypedia.com/records/483/california-fertility-centers-a-medical-corporation/4e53dc14-e3e1-440b-8644-b4bbe468dd83

> FDA 483 for California Fertility Centers, A Medical Corporation on January 24, 2020. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: California Fertility Centers, A Medical Corporation
- Inspection Date: 2020-01-24
- Product Type: biologics
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of California Fertility Centers, A Medical Corporation in Pasadena, CA, revealed significant deficiencies in their donor screening process. The firm failed to adequately screen gamete and oocyte donors for communicable disease agents, including Zika virus, and other critical risk factors. This was due to an incomplete "Gamete Donor Screening Questionnaire" that omitted essential questions for assessing donor eligibility.

## Related Officers

- [investigator](https://www.keypedia.com/people/yvonne-c-wilkes/44e7b094-d09a-48f0-a0ee-f1a6506f935a)

Company: https://www.keypedia.com/companies/california-fertility-centers-a-medical-corporation/9be05bd9-d10d-4462-b773-b52d24f439ad

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6